{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T21:00:05Z","timestamp":1778360405458,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.03.043","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T17:18:44Z","timestamp":1586452724000},"page":"3740-3746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5\u00a0years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines"],"prefix":"10.1016","volume":"38","author":[{"given":"Beatriz P.","family":"Quiambao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ambas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherylle","family":"Diego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Bosch Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Korejwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anvar","family":"Rasuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Houillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.043_b0005","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO). Rabies vaccines: WHO position paper \u2013 April 2018. Weekly epidemiological record. 2018;93:201\u201320.","DOI":"10.1016\/j.vaccine.2018.06.061"},{"key":"10.1016\/j.vaccine.2020.03.043_b0010","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.03.043_b0015","unstructured":"World Health Organisation (WHO). Rabies; 2019. Available at: https:\/\/wwwwhoint\/news-room\/fact-sheets\/detail\/rabies [30 September 2019)."},{"key":"10.1016\/j.vaccine.2020.03.043_b0020","doi-asserted-by":"crossref","first-page":"e1847","DOI":"10.1371\/journal.pntd.0001847","article-title":"Deaths from symptomatically identifiable furious rabies in India: a nationally representative mortality survey","volume":"6","author":"Suraweera","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.03.043_b0025","article-title":"Heterogeneity of Rabies Vaccination Recommendations across Asia","volume":"2","author":"Buchy","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.043_b0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/14760584.2018.1473765","article-title":"Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis","volume":"17","author":"Preiss","year":"2018","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2020.03.043_b0035","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.vaccine.2019.02.083","article-title":"Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines","volume":"37","author":"Quiambao","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.043_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.06.017","article-title":"Rapid fluorescent focus inhibition test optimization and validation: Improved detection of neutralizing antibodies to rabies virus","author":"Timiryasova","year":"2019","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.vaccine.2020.03.043_b0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2020.03.043_b0050","first-page":"491","article-title":"Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group","volume":"76","author":"Lang","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.03.043_b0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(86)91946-X","article-title":"New purified Vero-cell vaccine prevents rabies in patients bitten by rabid animals","volume":"2","author":"Suntharasamai","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.043_b0060","first-page":"1","article-title":"An evaluation of the safety and potency of equine rabies immunoglobulin through measurement of suppression on vaccine-induced antibody production among healthy volunteers","volume":"52","author":"Salva","year":"2014","journal-title":"Phillippine J Intern Med"},{"key":"10.1016\/j.vaccine.2020.03.043_b0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0264-410X(88)90225-3","article-title":"Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment","volume":"6","author":"Vodopija","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.043_b0070","doi-asserted-by":"crossref","first-page":"e0006340","DOI":"10.1371\/journal.pntd.0006340","article-title":"Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults","volume":"12","author":"Kerdpanich","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.03.043_b0075","doi-asserted-by":"crossref","first-page":"e0004920","DOI":"10.1371\/journal.pntd.0004920","article-title":"Persistence of rabies virus-neutralizing antibodies after vaccination of rural population following vampire bat rabies outbreak in Brazil","volume":"10","author":"Medeiros","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.03.043_b0080","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/hv.20471","article-title":"Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India","volume":"8","author":"Sudarshan","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.03.043_b0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1708-8305.2006.00097.x","article-title":"Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine","volume":"14","author":"Malerczyk","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.03.043_b0090","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4161\/21645515.2014.994460","article-title":"Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study","volume":"11","author":"Li","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.03.043_b0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1708-8305.2011.00540.x","article-title":"The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule\u2013a case series of 420 travelers","volume":"18","author":"Mills","year":"2011","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.03.043_b0100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1172\/JCI64096","article-title":"Causes, consequences, and reversal of immune system aging","volume":"123","author":"Montecino-Rodriguez","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2020.03.043_b0105","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/529197","article-title":"Biology of immune responses to vaccines in elderly persons","volume":"46","author":"Weinberger","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.043_b0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.7.4.467","article-title":"Age-related decline in immunity: implications for vaccine responsiveness","volume":"7","author":"Kumar","year":"2008","journal-title":"Expert Rev Vacc"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.03.043_b0115","doi-asserted-by":"crossref","first-page":"A94","DOI":"10.1016\/j.vaccine.2018.08.034","article-title":"Introduction of intradermal rabies vaccination - A paradigm shift in improving post-exposure prophylaxis in Asia","volume":"37","author":"Gongal","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.043_b0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/inthealth\/ihu071","article-title":"Human rabies deaths in Africa: breaking the cycle of indifference","volume":"7","author":"Dodet","year":"2015","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2020.03.043_b0125","doi-asserted-by":"crossref","first-page":"e0003709-e","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS NeglTrop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:09Z","timestamp":1759401849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":25,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20304229"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5\u00a0years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sanofi Pasteur. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}